Treatment of Cervical Spinal Cord Injury With Imatinib - a Safety and Feasibility Study

Summary

This is a phase II, single center, open-label, non randomized clinical study to assess the uptake, safety and tolerability of Imatinib in acute Cervical Spinal Cord Injury patients. The aim is to determine if Imatinib reaches sufficient blood levels when given to patients with cervical spinal cord injury, via a gastric feeding tube, and also evaluate the safety and tolerability of this drug treatment.

Timeline

Start

2018-04

Primary completion

2020-12

Completion

2021-12

Drugs

Indications